Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)
Apply
Zanidatamab
A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step